Prostate Cancer Trials

ENZAMET Trial

The prostate gland exists in men at the base of the bladder. There is a one in six chance of a man developing prostate cancer, but it can often be cured. Once prostate cancer spreads is it usually incurable. Treatment can range from surgery to chemotherapy to 'active surveillance'. Clinical trials are important to move many of these treatments forward.

Prostate cancer is the most common cancer in Australia. It can often be cured but if it spreads it can be very deadly.

The ENZAMET trial is for men with metastatic prostate cancer commencing androgen deprivation therapy.

The ENZARAD trial is for men with localised prostate cancer at high risk for recurrence deemed suitable for external beam radiation therapy.

This study is for men with advanced prostate cancer (proven metastatic disease or castrate resistant biochemical progression).

This trial is for men with localised prostate cancer at high risk for recurrence deemed suitable for external beam radiation therapy.

This study examines the implications for sexual practices and sexual identity in gay and bisexual men and their partners with prostate cancer.

© ANZUP 2017. All rights reserved.